Sun Pharmaceutical Industries Limited (SUNPHARMA): Basic Information
What is QVTQVT Stock Score
Sun Pharmaceutical Industries Ltd.Quality 95 /100 High Financial StrengthValuation 28 /100 Expensive ValuationTechnicals 35 /100 Technically BearishFalling CometGoodAverageBad
Sun Pharmaceutical Industries Ltd.SWOT Analysis
What is SWOT AnalysisStrengthsWeaknessOpportunityThreatsWhat is SWOT Analysis ?These are then classified as strengths, weaknesses, opportunities that investors can leverage, and threats that might impact company health.Strengths, Weaknesses, Opportunities and Threats Analysis is a real time check on stock health throughout the day. SWOT looks at financials, management quality, technical parameters and valuations to identify positives and negatives for every stock.
- Strengths
- Weakness
- Opportunity
- Threats
- Positive Breakout Third Resistance ( LTP > R3)
- Consistent Highest Return Stocks over Five Years
- Stocks with Consistent Share Price Growth (subscription)
- Rising Net Cash Flow and Cash from Operating activity
- Expensive Performers (DVM)
- PEG lower than Industry PEG
- Efficient in managing Assets to generate Profits - ROA improving since last 2 year
- Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
- Companies with Low Debt
- Increasing Revenue every quarter for the past 3 quarters
- Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
- Annual Net Profits improving for last 2 years
- Book Value per share Improving for last 2 years
- Stocks in uptrend most likely to cross above SMA-200 soon
- Top Gainers
- Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
- Stocks with Expensive Valuations according to the Trendlyne Valuation Score
- Weak Momentum: Price below Short, Medium and Long Term Averages
- Increasing Trend in Non-Core Income
- High promoter stock pledges
- Brokers upgraded recommendation or target price in the past three months
- Street Favorite: High Analyst Rating with at least 20% upside
- FII / FPI or Institutions increasing their shareholding
- MFs increased their shareholding last quarter
- Red Flags: Firms linked to ongoing regulatory investigations/legal cases
Products and Services:
- Pharmaceutical Products: Prescription drugs, over-the-counter (OTC) medications
- Therapeutic Areas: Neurology, psychiatry, cardiology, dermatology, oncology, gastroenterology
- Generics: Generic drugs for a wide range of diseases
- Active Pharmaceutical Ingredients (APIs): Bulk drugs and active ingredients for formulations
- Biotechnology: Biosimilars and biotech drugs
Key Financial Metrics (as of 2024):
- Revenue: ₹45,000 crore (approx.)
- Net Profit: ₹5,200 crore (approx.)
- Market Capitalization: ₹2.4 lakh crore (approx.)
Global Presence:
- Presence in over 150 countries worldwide
- Manufacturing and R&D facilities in India, the United States, and other international locations
- Leading provider of generic drugs and specialty medicines in global markets
Recognition:
- Ranked among the top global pharmaceutical companies
- Known for high-quality generics and specialty drugs
- Recognized for R&D and contributions to affordable healthcare worldwide
Sun Pharmaceutical Industries Limited (SUNPHARMA) is a leading global pharmaceutical company, renowned for its high-quality generic drugs, over-the-counter medications, and specialty products. Founded in 1983 by Mr. Dilip Shanghvi and headquartered in Mumbai, Sun Pharma has established itself as a dominant force in the pharmaceutical industry. The company specializes in a wide range of therapeutic areas, including neurology, oncology, dermatology, and cardiology, with a robust portfolio of generics and specialty medicines. Sun Pharma’s commitment to research and development has driven its growth, allowing it to bring innovative and affordable treatments to millions of people across the globe.
Similar to Reliance’s transformational influence in various sectors, Sun Pharma has become a cornerstone of the global healthcare industry, making healthcare more accessible and affordable. With a presence in over 150 countries and manufacturing facilities across the world, Sun Pharma continues to drive innovation, providing breakthrough treatments in areas like oncology and dermatology. Through its dedication to excellence and focus on patient care, Sun Pharmaceutical Industries has earned recognition as one of the world’s most trusted pharmaceutical companies.
Full Name: Sun Pharmaceutical Industries Limited
Type: Public Sector Pharmaceutical Company
Headquarters: Mumbai, Maharashtra, India
Founded: 1983
Founder: Mr. Dilip Shanghvi
Chairman & MD: Mr. Dilip Shanghvi (as of 2025)
Tagline: Caring for the World… one person at a time
Industry: Pharmaceuticals